Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study

PURPOSE: A novel transdermal formulation of granisetron (the granisetron transdermal delivery system (GTDS)) has been developed to deliver granisetron continuously over 7 days. This double-blind, phase III, non-inferiority study compared the efficacy and tolerability of the GTDS to daily oral granis...

Descripción completa

Detalles Bibliográficos
Autores principales: Boccia, Ralph V., Gordan, Lucio N., Clark, Gemma, Howell, Julian D., Grunberg, Steven M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166600/
https://www.ncbi.nlm.nih.gov/pubmed/20835873
http://dx.doi.org/10.1007/s00520-010-0990-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166600/
https://www.ncbi.nlm.nih.gov/pubmed/20835873
http://dx.doi.org/10.1007/s00520-010-0990-y

Ejemplares similares